Identifying Chemical Restraint in the Field

Course Overview

Research shows an over-reliance on the use of medication to address behaviours of concern in people with disability, despite the significant negative impact on health and wellbeing. Collaboration between the prescribing practitioner, behaviour support practitioner and the implementing service provider is crucial to good outcomes and the safe reduction and/or elimination of chemical restraints. This three-part webinar series is suitable for Positive Behaviour Support Practitioners, Implementing Providers and Support Coordinators.

Webinar 1: Identifying Chemical Restraint in the Field

• Recognise the different psychotropic medicines used for chemical restraint for people with intellectual and developmental disability and the implications of polypharmacy

• Identify the risks associated with the use of chemical restraint

• Understand the risks associated with psychotropic medicines

• Findings from the Disability Royal Commission on psychotropic medication, behaviour support and behaviours of concern

• Work with case study examples of collaboration between the pharmacist and BSP to reduce chemical restraint

• Identify red flags - observable behavioural signs which may indicate adverse effects of psychotropic medicines

• Make sense of medication charts

Collaborating Organisation

This webinar was delivered in partnership with